| HPV | Human Papillomavirus |
| RT | Radiation therapy |
| 5-FU | Fluorouracil |
| mAb | Monoclonal antibody |
| PD-1 | Programmed death receptor-1 |
| RTOG | Radiation Therapy Oncology Group |
| NEDD8 | Neural precursor cell expressed, developmentally-downregulated 8 |
| UBA3 | Ubiquitin-like modifier activating enzyme 3 |
| APPBP1 | NEDD8 activating enzyme E1 regulatory subunit |
| NAE | NEDD8 activating enzyme |
| UBC12 | NEDD8 conjugating enzyme Ubc12 |
| UBE2F | NEDD8 conjugating enzyme 2 |
| RBX1 | RING-box protein 1 |
| RBX2 | RING-box protein 2 |
| COP9 | Constitutive photomorphogenesis 9 |
| CRL | Cullin RING ligase |
| CAND1 | Cullin-associated NEDD8-dissociated protein 1 |
| p21 | Cyclin-dependent kinase inhibitor 1 |
| p27 | Cyclin-dependent kinase inhibitor 1b |
| Wee1 | WEE1 G2 checkpoint kinase |
| RING | Really interesting new gene |
| Ub | Ubiquitin |
| PEV | Pevonedistat |
| CDT1 | Chromatin licensing and DNA replication factor 1 |
| PI-FACS | Propidium Iodide-fluorescent activated cell sorting |
| AML | Acute myeloid leukemia |
| MM | Multiple myeloma |
| HNSCC | Head and neck squamous cell carcinoma |
| NOXA | Phorbol-12-myristate-13-acetate-induced protein 1 |
| BIM | Bcl-2-like protein 11 |
| BH3 | Bcl-2 homology 3 domain |
| TRAIL | Tumor necrosis factor-related apoptosis-inducing ligand |
| CDT2 | Denticleless protein homolog |
| Gy | Gray (unit of radiation) |
| Chk1 | Checkpoint kinase 1 |
| Chk2 | Checkpoint kinase 2 |
| γH2AX | Gamma H2A histone family member X |
| PR | Partial response |
| AUC6 | target area under the concentration-time curve of 6 mg/mL * min |
| ORR | Overall response rate |
| TAS | TAS4464 |
| DCN1 | Defective in Cullin NEDDylation 1 |
| IC50 | Half maximal inhibitory concentration |